Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Exenatide in Newly Diagnosed T2DM
NCT01776788Phase 4Completed
- Sponsor
- First Affiliated Hospital of Xiamen University
- Start
- Aug 2012
- Primary completion
- Feb 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by First Affiliated Hospital of Xiamen University. Started Aug 2012; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01776788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01776788.